Contrast-Enhanced Endoscopic Ultrasound Detects Early Therapy Response Following Anti-TNF Therapy in Patients with Ulcerative Colitis
Journal of Crohn's and Colitis · 06.08.2024 · 18 (7) · 1012-1024
DOI: 10.1093/ecco-jcc/jjae034 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Crohn's and Colitis, online erschienen am 08.03.2024. Verfasst von Mark Ellrichmann und 11 weiteren Autor:innen. Beteiligte Einrichtung: Interdisciplinary Endoscopy, Medical Department I, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Adalimumab, Infliximab, Endosonography. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: German Research Foundation.
Abstract (Originalsprache)
Background and Aims Though colonoscopy plays a crucial role in assessing active ulcerative colitis [aUC], its scope is limited to the mucosal surface. Endoscopic ultrasound [EUS] coupled with contrast-enhancement [dCEUS] can precisely quantify bowel wall thickness and microvascular circulation, potentially enabling the quantitative evaluation of inflammation. We conducted a prospective, longitudinal study to assess therapy response using dCEUS in aUC patients undergoing treatment with adalimumab [ADA] or infliximab [IFX].
Methods
Thirty ADA- and 15 IFX-treated aUC patients were examined at baseline and at 2, 6, and 14 weeks of therapy and 48 weeks of follow-up. Bowel wall thickness [BWT] was measured by EUS in the rectum. Vascularity was quantified by dCEUS using rise time [RT] and time to peak [TTP]. Therapy response was defined after 14 weeks using the Mayo Score.
Results
Patients with aUC displayed a mean BWT of 3.9 ± 0.9 mm. In case of response to ADA/IFX a significant reduction in BWT was observed after 2 weeks [p = 0.04], whereas non-responders displayed no significant changes. The TTP was notably accelerated at baseline and significantly normalized by week 2 in responders [p = 0.001], while non-responders exhibited no significant alterations [p = 0.9]. At week 2, the endoscopic Mayo score did not exhibit any changes, thus failing to predict treatment responses. Conclusion dCEUS enables the early detection of therapy response in patients with aUC, which serves as a predictive marker for long-term clinical success. Therefore, dCEUS serves as a diagnostic tool for assessing the probability of future therapy success.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Interdisciplinary Endoscopy, Medical Department I, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.
- Institute of Biomedical Optics, University of Luebeck, Luebeck, Germany.
- Department of Internal Medicine, Israelitic Hospital Hamburg, Hamburg, Germany.
- Institute of Pathology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.
ORCID-Profile: Mark Ellrichmann, Christoph Röcken
Förderung
- German Research Foundation
Zitieren
APA
Ellrichmann, M., Schulte, B., Conrad, C. C., Schoch, S., Bethge, J., Seeger, M., Huber, R., Goeb, M., Arlt, A., Nikolaus, S., Röcken, C., & Schreiber, S. (2024). Contrast-Enhanced Endoscopic Ultrasound Detects Early Therapy Response Following Anti-TNF Therapy in Patients with Ulcerative Colitis. Journal of Crohn's and Colitis, 18(7), 1012-1024. https://doi.org/10.1093/ecco-jcc/jjae034
Vancouver
Ellrichmann M, Schulte B, Conrad CC, Schoch S, Bethge J, Seeger M, et al. Contrast-Enhanced Endoscopic Ultrasound Detects Early Therapy Response Following Anti-TNF Therapy in Patients with Ulcerative Colitis. Journal of Crohn's and Colitis. 2024;18(7):1012-1024. doi:10.1093/ecco-jcc/jjae034
BibTeX
@article{Ellrichmann2024,
author = {Ellrichmann, Mark and Schulte, Berenice and Conrad, Claudio C and Schoch, Stephan and Bethge, Johannes and Seeger, Marcus and Huber, Robert and Goeb, Madita and Arlt, Alexander and Nikolaus, Susanna and Röcken, Christoph and Schreiber, Stefan},
title = {Contrast-Enhanced Endoscopic Ultrasound Detects Early Therapy Response Following Anti-TNF Therapy in Patients with Ulcerative Colitis},
journal = {Journal of Crohn's and Colitis},
year = {2024},
volume = {18},
number = {7},
pages = {1012--1024},
doi = {10.1093/ecco-jcc/jjae034}
}
EUVIMED